Vineet Laboratories Limited has intimated the stock exchanges about an upcoming board meeting scheduled for Monday, October 26, 2026. The primary purpose of this board meeting is to consider and approve the unaudited standalone financial results of the Company for the first quarter ended on June 30, 2026, along with the Limited Review Report.
The disclosure is made in compliance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company also confirms that the trading window for dealing in the equity shares of the Company remains closed for all Designated Persons, their immediate relatives, and other connected persons covered under the Company's Code of Conduct. This closure is in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015 and will remain effective until 48 hours after the declaration of the financial results for the quarter ended September 30, 2026.
The intimation is signed by Rajesh Kumar Kathulla, Director (DIN: 05349717), and is addressed to both BSE Limited and National Stock Exchange of India Limited.